International Public Health Agency
Appears in 9 stories
Leading global antimicrobial resistance surveillance and priority-setting
No genuinely new class of antibiotic has reached patients since 1987. In the nearly four decades since, bacteria have steadily evolved resistance to existing drugs, and carbapenem-resistant Acinetobacter baumannii—a hospital-acquired pathogen that kills up to 60 percent of ventilated pneumonia patients—now sits atop the World Health Organization's list of critical-priority threats. On March 16, 2026, Swiss biotech BioVersys received clearance from the United States Food and Drug Administration (FDA) to begin enrolling American patients in a Phase 3 pivotal trial of BV100, a drug that cut 28-day mortality in half during earlier testing.
Updated Yesterday
Administering the global validation process for EMTCT elimination
Every year, roughly 120,000 children worldwide are born with HIV they could have avoided. Denmark just proved that number can be zero. On February 27, 2026, the World Health Organization validated Denmark as the first European Union country to eliminate mother-to-child transmission of both HIV and syphilis, confirming that routine prenatal screening and treatment drove new infant infections to zero across four consecutive years.
Updated Feb 28
Leading global cancer prevention strategy
Four in ten cancer cases worldwide could be prevented. That finding, from the World Health Organization's International Agency for Research on Cancer, marks the first time researchers have quantified the combined burden of behavioral, environmental, occupational, and infectious causes of cancer using global data from 185 countries. The analysis, published in Nature Medicine ahead of World Cancer Day, estimates that 7.1 million cancer cases in 2022 were linked to just 30 modifiable risk factors.
Updated Feb 19
Coordinating global elimination campaign
For the first time since records began, fewer than 100 million people need treatment for trachoma—a bacterial eye disease that's been blinding humans since ancient Egyptian times. The number at risk has cratered 94% since 2002, from 1.5 billion to 97 million. Twenty-seven countries have eliminated it entirely, making trachoma one of the success stories celebrated at World NTD Day 2026 on January 30.
Updated Jan 30
Primary coordinator of global health efforts
In 1950, the average human lived 47 years. Today, it's 73. The global age-standardized mortality rate has dropped 67% over that span—driven not by a single breakthrough but by the compounding effects of vaccines, clean water, antibiotics, and basic sanitation reaching billions of people who previously lacked access. Lower respiratory infections (LRIs)—once the leading cause of infectious disease death—killed 2.5 million people in 2023, down 33% among children under five since 2010.
Updated Jan 25
Lead agency for maternal mortality estimation and target-setting
In 1990, approximately 532,000 women died each year from pregnancy and childbirth complications. By 2015, that number had fallen to 303,000—a 44% reduction in the maternal mortality ratio, from 385 to 216 deaths per 100,000 live births. The decline represents one of the largest coordinated public health efforts in history, driven by expanded access to skilled birth attendants, emergency obstetric care, and basic medical interventions like antibiotics and blood transfusions.
Updated Jan 22
Primary global health coordinating body
For most of human history, the average person could expect to live about 30 years. Two centuries of accumulated advances—clean water, sanitation, vaccines, antibiotics, nutrition, and poverty reduction—have more than doubled that figure to 72 years globally. The change is so comprehensive that the global average today exceeds what the healthiest country achieved in 1950.
Active; coordinates global immunization and child health programs
In 1900, one in seven babies born in the United States or United Kingdom died before their first birthday. By 2017, the rate had fallen to roughly 4-6 per 1,000—a decline exceeding 95%. This transformation ranks among the most consequential achievements in human history, fundamentally altering how families experience childbirth and early childhood.
Set 75% efficacy target; approved two vaccines for rollout
NIH researchers discovered a new class of antibodies that attack malaria parasites at a never-before-targeted site. The antibody MAD21-101 protected four out of five mice from infection and works differently than existing vaccines, binding to a cryptic protein fragment exposed only after the parasite undergoes a specific chemical transformation called pyroglutamylation. The breakthrough opens a fresh avenue in the decades-long hunt for a highly effective malaria vaccine.
Updated Jan 7
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
